Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 10/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.50 |
| ▸ | RELA | Q04206 | 2/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.38 |
| ▸ | GAPDH | P04406 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.37 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Blxa4 SCHEMBL10000537 | 0.90 | FPR2 (0.63) | FPR2NFKB1NFKB2RELAMAPT | |
| Blxa4 SCHEMBL29563817 | 0.90 | FPR2 (0.63) | FPR2NFKB1NFKB2RELAMAPT | |
| SCHEMBL15942742 | 0.88 | NFKB1 (0.50) | FPR2NFKB1NFKB2RELA | |
| SCHEMBL29564346 | 0.87 | NFKB1 (0.65) | FPR2NFKB1NFKB2RELA | |
| SCHEMBL22956003 | 0.87 | NFKB1 (0.65) | FPR2NFKB1NFKB2RELA | |
| SCHEMBL29935444 | 0.87 | NFKB1 (0.65) | FPR2NFKB1NFKB2RELA | |
| SCHEMBL590255 | 0.87 | NFKB1 (0.65) | FPR2NFKB1NFKB2RELA | |
| SCHEMBL590253 | 0.87 | NFKB1 (0.65) | FPR2NFKB1NFKB2RELA | |
| SCHEMBL590254 | 0.87 | NFKB1 (0.65) | FPR2NFKB1NFKB2RELA | |
| SCHEMBL590256 | 0.87 | NFKB1 (0.65) | FPR2NFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170172967-A1 | Benzo Lipoxin Analogues | UNIVERSITY OF SOUTHERN CALIFORNIA | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170172967-A1 | Benzo Lipoxin Analogues | ALOX15B, ALOX12, ALOX15 | FPR2 238/4885NFKB1 175/4885NFKB2 265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.